Information Provided By:
Fly News Breaks for September 11, 2018
Sep 11, 2018 | 08:19 EDT
Craig-Hallum analyst Alexander Nowak started Misonix with a Buy rating and $28 price target. The analyst notes that Misonix develops and commercializes a range of ultrasonic surgical tools for use in orthopedics and wound debridement, which he believes are the next evolution in surgical tools and could become standard of care in ORs due to their unique benefits over traditional surgical equipment.
News For MSON From the Last 2 Days
There are no results for your query MSON